Transforming growth factor B 1 T29C polymorphism and breast cancer risk in Japanese Women

Breast Cancer

Volumn 10, Issue 1, 2003, Pages 63-69

  Hishida, Asahi ^a,b   Iwata, Hiroji ^a   Hamajima, Nobuyuki ^a   Matsuo, Keitaro ^a,b   Mizutani, Mitsuhiro ^a   Iwase, Takuji ^a   Miura, Shigeto ^a   Emi, Nobuhiko ^b   Hirose, Kaoru ^a   Tajima, Kazuo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer risk; Lifestyle factors; TGF B 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; ASIAN; BODY MASS; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTOR;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0041808967     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967627     Document Type: Article

References (38)

1. Dunning AM, Healey CS, Pharoah PD, et al: A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prey 8:843-854, 1999. (Pubitemid 29508718)
2. Martin A-M, Weber BL: Genetic and hormonal risk factors in breast cancer. J Natl Cancer Res 92:1126-1135, 2000.
3. Chang-Claude J: Inherited genetic susceptibility to breast cancer. In: Miller AB, Bartsch H, Boffetta P, Dragsted L, Vainio H eds, Biomarkers in Cancer Chemoprevention. IARC Scientific Publications No. 154, International Agency for Research on Cancer, Lyon, pp177-191, 2001.
4. Yokota M, Ichihara S, Lin T-L, et al: Association of a T29→ C polymorphism of the transforming growth factor-ill gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101:2783-2787, 2000. (Pubitemid 30396007)
5. Ziv E, Cauley J, Morin PA, et al: Association between the T29→C polymorphism in the transforming growth factor fll gene and breast cancer among elderly white women: the study of osteoporotic fractures. JAm Med Assoc 288:2859-2863, 2001. (Pubitemid 32537349)
6. Kojima S, Harpel PC, Rifkin DB: Lipoprotein(a) inhibits the generation of transforming growth factorjg: an endogenous inhibitor of smooth muscle cell migration.J Cell Biol 113:1439-1445, 1991. (Pubitemid 21909770)
7. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor beta in human disease. N Engl JMed 342:1350-1358, 2000. (Pubitemid 30408720)
8. Tang B, Bottinger EP, Jakowlew SB, et al: Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med 4:802-807, 1998. (Pubitemid 28331021)
9. Pierce DF Jr., Gorska AE, Chytil A, et al: Mammary tumor suppression by transforming growth factor β transgene expression. Proc Natl Acad Sci USA 92:4254-4258, 1995.
10. Pasche B, Kolachana P, Nafa K, et al: TBR-I(6A) is a candidate tumor susceptibility allele. Cancer Res 59:5678-5682, 1999.
11. Gobbi H, Dupont WD, Simpson JF, et al: Transforming growth factor fl and breast cancer risk in women with mammary epithelial hyperplasia. J Natl Cancer Inst 91:2096-2101, 1999. (Pubitemid 30019570)
12. Murray PA, Barrett-Lee P, Travers M, et al: The prognostic significance of transforming growth factors in human breast cancer. BrJ Cancer 67:1408-1412, 1993. (Pubitemid 23172888)
13. Sheen-Chen SM, Chen HS, Sheen CW, et al: Serum levels of transforming growth factor fl I in patients with breast cancer. Arch Surg 136:937-940, 2001.
14. Derynck R, Rhee L, Chen EY, et al: Intron-exon structure of the human transforming growth factor-fl precursor gene. Nucleic Acids Res 15:3188-3189, 1987.
15. Cambien F, Ricard S, Troesch A, et al: Polymorphisms of the transforming growth factor-fl i gene in relation to myocardial infarction and blood pressure. Hypertension 28:881-887, 1996.
16. Langdahl BL, Knudsen JY, Jensen HK, et al: A sequence variation: 713-8delC in the transforming growth factor1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 20:289-294, 1997. (Pubitemid 27141842)
17. Syrris P, Carter ND, Metcalfe JC, et al: Transforming growth factor-ill gene polymorphisms and coronary artery disease. Clin Sci 95:659-667, 1998. (Pubitemid 29034430)
18. Grainger D J, Healthcote K, Chiano M, et al: Genetic control of the circulating concentration of transforming growth factor type β l. Hum mol Genet 8:93-97, 1999. (Pubitemid 29039053)
19. 69→,C polymorphism, of the transforming growth factor-ill gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. J Mol Med 79:149-156, 2001. (Pubitemid 32285341)
20. Hamajima N, Iwata H, Obata Y, et al: No association of the 5" promoter region polymorphism of CYP17 with breast cancer risk in Japan. Jpn J Cancer Res 91:880-885, 2000.
21. Hamajima N, Matsuo K, Tajima K, et al: Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. IntJ Clin Oncol 6:13-18, 2001. (Pubitemid 32230357)
22. Huang X-E, Hamajima N, Saito T, et al: Possible association of β2- and β3- receptor gene polymorphisms with susceptibility to breast cancer. Br Cancer Res 3:264-269, 2001. (Pubitemid 32631704)
23. Hamajima N, Hirose K, Inoue M, et al: Age specific risk factors of breast cancer estimated by a case-control study in Japan.JEpidemiol 5:99-105, 1995.
24. Tajima K, Hirose K, Inoue M, et al: A model of practical cancer prevention for out-patients visiting a hospital: the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Asian Pacific J Cancer Prev 1:35-47, 2000.
25. Hamajima N, Saito T, Matsuo K, et al: Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 91:865-868, 2000.
26. Lynch MA, Petrel TA, Song H, et al: Responsiveness to transforming growth factor-fl (TGF-B)-mediated growth inhibition is a function of membrane-bound TGF-fl type II receptor in human breast cancer cells. Gene Expr 9:157-171, 2001. (Pubitemid 32606839)
27. Matsuda T, Yamamoto T, Muragnchi A, et al: Crosstalk between transforming growth factor-β and estrogen receptor signaling through Smad3. J Biol Chem 276:42908-42914, 2001.
28. l0→ polymorphism of the transforming growth factor-ill with genetic susceptibility to osteoporosis and spinal osteoarthritis. Mech Ageing Dev 116:113-123, 2000.
29. Yamada Y, Miyauchi A, Goto J, et al: Association of a polymorphism of the transforming growth factorbeta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 13:1569-1576, 1998. (Pubitemid 28465297)
30. Yamada Y: Association of polymorphisms of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis. Pharmacogenetics 11:765-771, 2001. (Pubitemid 33151511)
31. Pociot F, Hansen PM, Karlsen AE, et al: TGF-βl gene mutations in insulin-dependent diabetes mellitus and diabetic nephropathy. Am Soc Nephrol 9:2302-2307, 1998. (Pubitemid 28543808)
32. Luedecking EK, DeKosky ST, Mehdi H, et al: Analysis of genetic polymorphisms in the transforming growth factor-t1 gene and the risk of Alzheimer's disease. Hum Genet 106:565-569, 2000. (Pubitemid 30406684)
33. Hobbs K, Negri J, Klinnert M, et al: Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 158:1958-1962, 1998. (Pubitemid 29008839)
34. Linden GJ, Haworth SE, Maxwell AP, et al: The influence of transforming growth factor-beta1 gene polymorphism on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker. J Periodontol 72:808-814, 2001. (Pubitemid 32565612)
35. Holweg CT, Baan CC, Balk AH, et al: The transforming growth factor-betal codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation 71:1463-1467, 2001. (Pubitemid 32507122)
36. Hirose K, Tajima K, Hamajima N, et al: Association of family history and other risk factors with breast cancer risk among Japanese premenopausal and postmenopausal women. Cancer Causes Control 12:349-358, 2001. (Pubitemid 32553628)
37. Hamajima N, Matsuo K, Yuasa H: Adjustment of prognostic effects in prevalent case-control studies on genotype. J Epidemiol 11:204-210, 2001. (Pubitemid 33798367)
38. Corrections 11:288, 2001.